ArticleArchives of microbiology2025
Increased production of riboflavin in Ashbya gossypii by endoplasmic reticulum stresses.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Engineering Bacillus Subtilis for Efficient Biosynthesis of Riboflavin: Current Knowledge and Future Perspectives.Applied biochemistry and biotechnology · 2026Review
- ROS-CaArchives of microbiology · 2026Article
- Biosynthesis, Regulation, and Biotechnological Production Strategies of Riboflavin (Vitamin BPharmaceuticals (Basel, Switzerland) · 2026Review
- Hog1 MAP kinase modulates early riboflavin accumulation under low-pH and saline conditions inFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
A filamentous fungus Ashbya gossypii overproduces riboflavin. However, what is a trigger to produce riboflavin in A. gossypii has not yet been elucidated. In the present study, we reveal the mechanism, by investigating riboflavin production in A. gossypii with respect to endoplasmic reticulum (ER) stresses. Addition of a reducing agent, dithiothreitol (DTT), to the culture medium at 10 mM resulted in more yellowish mycelia compared to the that of wild type strain, enhanced specific riboflavin production by approximately 1.7-fold, and an increase in the expression of several rib genes, AgRIB1, AgRIB2, and AgRIB7. Additionally, the production of reactive oxygen species (ROS) and expression of antioxidant genes, AgGLR1 and AgSOD1, were also induced. The ER stressor, tunicamycin, which inhibits the addition of N-glycan to glycoproteins in the ER, also enhanced the riboflavin production by 1.8 fold with the production of ROS and the increase of the expression of AgRIB3 and AgRIB4 genes. These results indicate that ER stress enhances riboflavin production in A. gossypii through the production of ROS; however, the mechanism of ER stress-induced riboflavin production has not yet been revealed. This study reveals why A. gossypii naturally overproduces riboflavin. This study shows the different mechanisms of the riboflavin over-production by ER stressors, DTT and tunicamycin. Additionally, cycloheximide, which inhibits protein synthesis and induces apoptosis, enhanced the riboflavin production. These results suggest that apoptosis induced by ER stresses may partially enhance the riboflavin production in A. gossypii. DTT and tunicamycin can be utilized to reveal why the riboflavin overproduction is conducted in A. gossypii, leading to the generation of riboflavin-hyperproducing A. gossypii mutants for efficient industrial riboflavin production.
Indexed as
Identifiers
40471373What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.